Track Hinge Health, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Hinge Health, Inc. HNGE · Stock Open Hinge Health, Inc. in new tab

77.65 USD
EPS
-8.91
P/B
53.74
ROE
-136.00
Target Price
92.67 USD
Loading chart...
Key Metrics
Earnings dateAug. 4, 2026
EPS-8.91
Book Value1.45
Price to Book53.74
Debt/Equity2.24
% Insiders5.810%
Growth
Revenue Growth0.47%
Earnings Growth-0.68%
Estimates
Forward P/E22.83
Forward EPS3.40
Target Mean Price92.67

DCF Valuation

Tweak assumptions to recompute fair value for Hinge Health, Inc. (HNGE)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Hinge Health, Inc. Logo Hinge Health, Inc. Analysis (HNGE)

USA Official Website Stock

Is Hinge Health, Inc. a good investment? Hinge Health, Inc. (HNGE) is currently trading at 77.65 USD. Market analysts have a consensus price target of 92.67 USD. This suggests a potential upside from current levels.

Earnings Schedule: Hinge Health, Inc. is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is 3.40.

Investor FAQ

Does Hinge Health, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Hinge Health, Inc.?

Hinge Health, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of -8.91.

Company Profile

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

Exchange Ticker
US HNGE
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion